The lack of collaboration with the American public--and even more importantly the Congress--on trade-related activities is, let us say unwise.
Thom Tillis
The Public Record
Thom Tillis is an American politician and businessman currently serving as the junior United States senator from North Carolina, a position he has held since January 6, 2015. A member of the Republican Party, Tillis has focused on issues such as tax reform, healthcare, and national security during his tenure in the Senate. He previously served as the Speaker of the North Carolina House of Representatives from 2011 to 2012, where he played a significant role in shaping state legislation.
If it proves to be efficacious then you all should be coming back to us and saying that these temporary authorities need to be reinstated.
We have got to fix it because you are not going to be successful no matter how hard you work.
If you are really going to fix the fundamental problems with drug pricing and look people in the eye and say you are doing something not just to claim victory, as it was done with the IRA, but something that is sustainable, every single…
I think, based on patterns that I am seeing in the industry, you could call it the Investment Reduction Act.
The only reason, the primary reason I did not support your confirmation...is the position you have taken on march-in rights.
Please study up on the attacks on intellectual property protections; take a look at what the administration's done with TRIPS waivers and other things, really threatening the return on investment that these companies have to make.
I believe we are going about it the wrong way in terms of the haircut that needs to be done to get prescription prices lower.
I've got a vested interest in broader research. I've got two potentially deadly--one incurable and one curable--diseases in my body.
The only reason, the primary reason I did not support your confirmation...is the position you have taken on march-in rights.
Please study up on the attacks on intellectual property protections; take a look at what the administration's done with TRIPS waivers and other things, really threatening the return on investment that these companies have to make.
I believe we are going about it the wrong way in terms of the haircut that needs to be done to get prescription prices lower.





